PRONULIFE®GlukoSolu

Booth No: J216

Characteristic

Glac Biotech's Research and Development Center has carefully selected the most promising strains for carbohydrate utilization in their PRONULIFE®GlukoSolu formulation: Bifidobacterium animalis subsp. lactis CP-9, Lactobacillus johnsonii MH-68, and Lactobacillus salivarius AP-32. Research has demonstrated that Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 can protect β-cells, stabilize blood sugar levels to prevent large fluctuations, and help increase the abundance of beneficial gut bacteria.

【Patent】
I777475

Glac Biotech has established itself in the field of probiotics, leveraging decades of scientific research and big data platform analysis to continuously optimize probiotic manufacturing processes. By integrating modern gene chip technology, they developed the globally unique PRONEX® probiotic manufacturing technology. With world-leading probiotic production capabilities, they utilize professional expertise to extend product value and establish PRIMETEK® probiotic ODM technology.

【Read more】https://en.glac.com.tw/data-80311

Other Products

Products you may be interested in

Highest Rated Products

Back

Menu

PRONULIFE®GlukoSolu

Characteristic

Other Products

Products you may be interested in

Highest Rated Products